Marshall Summar, MD to testify on behalf of NORD (National Organization for Rare Disorders) at 21st Century Cures Hearing in Washington, D. C. , Friday, July 11 at 9 AM ET.
The 21st Century Cures initiative is focused on identifying ways to promote innovation in medical research and the development of treatments for unmet medical needs. Launched by the House Energy & Commerce Committee, it is taking a comprehensive look at drug discovery, development, and delivery processes to identify ways to bridge gaps between advances in scientific knowledge and delivery of innovative treatments and cures to patients.
Other speakers will be: Janet Woodcock, MD, Director of FDA’s Center for Drug Evaluation and Research; Richard F. Pops, Chairman and CEO, Alkermes; Robert J. Beall, PhD, President and CEO, Cystic Fibrosis Foundation; Pat Furlong (also a NORD Board member), Founding President and CEO, Parent Project Muscular Dystrophy; and Leonard Lichtenfeld, MD, Deputy Chief Medical Officer, American Cancer Society.
For further details, click here.
Click here the 21st Century Cures website for more details.